Antineutrophil cytoplasmic antibodies in Wegener's granulomatosis

Archives of Disease in Childhood

Volumn 79, Issue 3, 1998, Pages 246-250

  Wong, S N ^a   Shah, V ^a   Dillon, M J ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Antineutrophil cytoplasmic antibodies; Wegener's granulomatosis

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADOLESCENT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; INFANT; MALE; PREVALENCE; PRIORITY JOURNAL; WEGENER GRANULOMATOSIS;

EID: 0031662626     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.79.3.246     Document Type: Article

References (22)

1. Rottem M, Fauci AS, Hallahan CW, et al. Wegener granulomatosis in children and adolescents: clinical presentation and outcome. J Pediatr 1993;122:26-31.
2. Van Der Woude FJ, Rasmussen N, Lobatto S, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985;i:425-9.
3. Savage CO, Winearls, Jones S, Marshall BD, Lockwood CM. Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet 1987;i:1389-93.
4. Wiik AS. Anti-neutrophil cytoplasmic antibodies in primary small vessel vasculitides. Scand J Rheumatol 1996;25:65-9.
5. Venning MC, Quinn A, Broomhead V, Bird AG. Antibodies directed against neutrophils (C-ANCA and P-ANCA) are of distinct diagnostic value in systemic vasculitis. QJM 1990;77:1287-96.
6. Egner W, Chapel HM. Titration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitides. Clin Exp Immunol 1990;82:244-9.
7. Pall AA, Savage CO. Mechanisms of endothelial cell injury in vasculitis. Springer Semin Immunopathol 1994;16:23-37.
8. Gross WL, Csernok E, Helmchen U. Antineutrophil cytoplasmic autoantibodies, autoantigens, and systemic vasculitis. APMIS 1995;103:81-97.
9. Lesavre P. Antineutrophil cytoplasmic autoantibodies antigen specificity. Am J Kidney Dis 1991;18:159-63.
10. Ellis EN, Wood EG, Berry P. Spectrum of disease associated with anti-neutrophil cytoplasmic autoantibodies in paediatric patients. J Pediatr 1995;126:40-3.
11. Nash MC, Dillon MJ. Antineutrophil cytoplasm antibodies and vasculitis. Arch Dis Child 1997;77:261-4.
12. Leavitt RY, Fauci AS, Bloch DA, Michel BA. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33: 1101-7.
13. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS 1989; 97(suppl):12-13.
14. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-42.
15. Bajema IM, Hagen EC, Van der Woude EJ, Bruijn JA. Wegener's granulomatosis: a meta-analysis of 349 literary case reports. J Lab Clin Med 1997;129:17-22.
16. Rao JK, Weinberger M, Oddone EC, et al. The role of antineutrophil cytoplasmic (c-ANCA) testing in the diagnosis of Wegener granulomatosis: a literature review and meta-analysis. Ann Intern Med 1995;123:925-32.
17. Savage COS, Harper L, Adu D. Primary systemic vasculitis. Lancet 1997;349:553-8.
18. Cohen Tervaert JW, Huitema MG, Hene RJ, et al. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasm antibody titre. Lancet 1990;336:709-11.
19. Kerr GS, Fleisher TA, Hallahan CW, Leavitt RY, Fauci AS, Hoffman GS. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum 1993;36:365-71.
20. Nash MC, Jones CL, Walker RG, Powell HR. Antineutrophil cytoplasmic antibody-associated glomerulonephritis in children. Pediatr Nephrol 1993;7:11-14.
21. Esnault VLM, Soleimam B, Keoogan MT, Brownlee AA, Jayne DRW, Lockwood CM. Association of IgM with IgG ANCA in patients presenting with pulmonary hemorrhage. Kidney Int 1992;41:1304-10.
22. Thomas DM, Moore R, Donovan K, Wheeler DC, Esnault VLM, Lockwood CM. Pulmonary-renal syndrome in association with anti-GBM and IgM ANCA. Lancet 1992; 339:1304.